Full article: Colonization and infection with extended spectrum beta-lactamase producing
Enterobacteriaceae in high-risk patients – Review of the literature from a clinical perspective …

… Community-acquired bacteraemia due to extended-spectrum betalactamase-producing …
Bacteremia caused by Escherichia coli producing extendedspectrum beta-lactamase: a …

… ) and are inhibited by β-lactamase inhibitors, such as clavulanic acid, … a clinical
perspective to review the clinical efficacy of the less-affected cephalosporins and of β-lactam/β-lactamase …

… We propose that from a clinical perspective we need a revised, comprehensible
nomenclature scheme, which facilitates smooth communication of clinically important β-lactamases. …

… Citation23 Some special OXA-type β-Lactamase, OXA‐10 and OXA‐13 to OXA‐19, also
hydrolyze extended spectrum cephalosporins and they are also regarded as ESBLs. Citation26 …

… Extended-spectrum beta-lactamases (ESBLs) are one of the most common defence … In
the early 1980s, broad spectrum-cephalosporins (BSCs) were introduced into clinical practice. …

Extended-spectrum β-lactamase (ESBL)-producing bacteria have been spreading from
hospitals to communities. Despite this, there are limited emergency department (ED) patient-…

… Extended spectrum beta-lactamase producing gram-negative bacteria are frequent culprits
in different types of infections in clinical practice worldwide. Although the data are limited to …

… Characterization of extendedspectrum beta-lactamases produced by Escherichia coli isolated
… Extended-spectrum betalactamases in ambulatory care: a clinical perspective. Clin Micro…

… In this review, we provide a clinical perspective on the management of patients infected or
… The aim of this review was to provide a clinical perspective on CPE. We discuss herein the …